when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Hematology · news · pharmadog

← back to Hematology

News · Hematology

411 stories

Jul 8, 26Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsstat

Jul 7, 26Kailera says obesity pill succeeds in late-stage trial in Chinabiopharma dive

Jul 7, 26Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trialsendpoints

Jul 7, 26Infusion Pump Correction: Fresenius Kabi Issues Correction for Ivenix Large Volume Infusion Pumpfda medwatch

Jul 7, 26Infusion Pump Correction: Fresenius Kabi Issues Correction for dropped or jarred Ivenix Large Volume Infusion Pumpsfda medwatch

Jul 6, 26Opinion: Stopping doctors from ordering unnecessary diagnostic tests requires a structural fixstat

Jul 6, 26Convenience Kit Correction: Windstone Medical Packaging, Inc. Issues Correction for Convenience Kitfda medwatch

Jul 2, 26STAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrongstat

Jul 2, 26STAT+: A year after distressed buyout, what’s become of Bluebird Bio?stat

Jul 2, 26STAT+: A ‘historic’ FDA clearance raises the question: Is the LLM an interface or the decision-maker?stat

Jul 1, 26Statins and blood pressure drugs changing health risks of obesity, study suggestsstat

Jul 1, 26FDA Approves First Gene Therapy for Young Children with Sickle Cell Diseasefda press

Jul 1, 26FDA approves Orca Bio’s cell therapy to improve transplant outcomesendpoints

Jul 1, 26BridgeBio gets funding for drug launch; United buys into cell therapybiopharma dive

Jul 1, 26STAT+: Synthetic biology researchers think they’ve made a cell. Is it alive?stat

Jul 1, 26Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M dealbiopharma dive

Jul 1, 26STAT+: More signs that GLP-1s may help with peripheral artery diseasestat

Jul 1, 26STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patientsstat

Jul 1, 26STAT+: The biotech scorecard for the third quarter: 15 stock-moving events to watchstat

Jun 30, 26FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patientsfda press

Jun 30, 26Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot programbiopharma dive

Jun 30, 26STAT+: FDA digital leader hints at coming AI policy updatesstat

Jun 29, 26FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturingfda press

Jun 29, 26STAT+: 26 states sue to block Medicaid work requirementsstat

Jun 29, 26STAT+: Longevity, wellness physicians named to panel advising FDA on peptidesstat

Jun 29, 26Theravance, after clinical setbacks, agrees to $929M buyoutbiopharma dive

Jun 29, 26Ipsen to buy blood cancer company Kartos Therapeutics for $450M upfrontendpoints

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 26, 26On second try, Acadia drug gets nod from European regulatorsbiopharma dive

Jun 18, 26STAT+: Do wearables actually help people with cardiovascular disease?stat

← prevpage 7 of 14next →